A1C Cut Points to Define Various Glucose Intolerance Groups in Asian Indians

Objective: To determine A1C cut points for glucose intolerance in Asian Indians. Research Design and Methods: A total of 2,188 participants without known diabetes were randomly selected from the Chennai Urban Rural Epidemiology Study. All had fasting plasma glucose (FPG) and 2-h postload plasma glucose measurements after a 75-g load and were classified as having impaired fasting glucose (IFG) (American Diabetes Association [ADA] criteria, FPG ≥5.5 and &lt;7 mmol/l, and World Health Organization [WHO] criteria, FPG ≥6.1 and &lt;7 mmol/l), impaired glucose tolerance (IGT) (2-h postload plasma glucose ≥7.8 and &lt;11.1 mmol/l), or diabetes (FPG ≥7 mmol/l and/or 2-h postload plasma glucose ≥11.1 mmol/l). A1C was measured using the Bio-Rad Variant machine. Based on receiver operating characteristic curves, optimum sensitivity and specificity were derived for defining A1C cut points for diabetes, IGT, and IFG. Results: Mean ± SD values of A<SUB>1</SUB>C among subjects with normal glucose tolerance, IGT, and diabetes were 5.5 ± 0.4, 5.9 ± 0.6, and 8.3 ± 2.0%, respectively (P<SUB>trend</SUB> &gt; 0.001) with considerable overlap. To identify diabetes based on 2-h postload plasma glucose, the A1C cut point of 6.1% had an area under the curve (AUC) of 0.941 with 88.0% sensitivity and 87.9% specificity. When diabetes was defined as FPG ≥7.0 mmol/l, the A1C cut point was 6.4% (AUC = 0.966, sensitivity 93.3%, and specificity 92.3%). For IGT, AUC = 0.708; for IFG, AUC = 0.632 (WHO criteria) and 0.708 (ADA criteria), and the A1C cut point was 5.6%. Conclusions: In Asian Indians, A1C cut points of 6.1 and 6.4% defined diabetes by 2-h postload plasma glucose or FPG criteria, respectively. A value of 5.6% optimally identified IGT or IFG but was &lt;70% accurate

Antioxidant status in polycystic end-staged renal diseased patients and antihemolytic effect of <i style="">Boerhaavia diffusa</i>

269-272Chronic renal failure (CRF) induces anaemia by shortening the life-span of erythrocytes, due to an increase in oxidative stress, which is considered to be one of the major risk factors in CRF patients undergoing hemodialysis. In the present study, the antioxidant status of the end-staged renal disease (ESRD) patients was investigated. The antihemolytic activity of Boerhaavia diffusa on the erythrocytes of the patients was also studied. Protein, lipid peroxides (LPO), reduced glutathione (GSH) levels and glutathione peroxidase (GPX) and glutathione-S-transferase (GST) activities were measured in the hemolysate from 55 polycystic ESRD patients (Group II) and compared with normal subjects (Group I). The antioxidant status was found to be significantly reduced in the patients as compared to normal healthy volunteers, due to increased oxidative stress. Also, aqueous extract of B. diffusa showed a significant antihemolytic activity on the erythrocytes of the polycystic ESRD patients.